Numerous systematic reviews and meta-analyses have demonstrated the favorable effects of the MD on NAFLD, positively influencing a variety of variables such as ALT concentrations, liver fat percentage, and HOMA-IR scores [38,39,40]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.